Thus eIF5A-2 overexpression increases growth, glucose uptake and lactate secretion by up-regulating glycolytic enzymes [71], which is precisely the metabolic reprogramming that occurs in most cancer cells [72]. This evidence concerns the gene EIF5A2 and cancer.